426 - 450 of 8436 Results
Title
Year
-
OPENTitle: APOE contributes to longitudinal impulse control disorders progression in Parkinson’s diseaseJournal Name: BMC PsychiatryPublisher: Springer Science and Business Media LLCVol: 24Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1186/s12888-024-06084-5Best OA location URL: https://doi.org/10.1186/s12888-024-06084-5Citation Count: 0
- Modulation of cannabinoid receptor 2 alters neuroinflammation and reduces formation of alpha-synuclein aggregates in a rat model of nigral synucleinopathy2024OPENTitle: Modulation of cannabinoid receptor 2 alters neuroinflammation and reduces formation of alpha-synuclein aggregates in a rat model of nigral synucleinopathyJournal Name: Journal of NeuroinflammationPublisher: Springer Science and Business Media LLCVol: 21Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12974-024-03221-5Citation Count: 2
- Neuronal alpha-Synuclein Disease integrated staging system performance in PPMI, PASADENA, and SPARK baseline cohorts2024OPENTitle: Neuronal alpha-Synuclein Disease integrated staging system performance in PPMI, PASADENA, and SPARK baseline cohortsJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-024-00789-wBest OA location URL: https://doi.org/10.1038/s41531-024-00789-wCitation Count: 8
- VPS13B is localized at the interface between Golgi cisternae and is a functional partner of FAM177A12024OPENTitle: VPS13B is localized at the interface between Golgi cisternae and is a functional partner of FAM177A1Journal Name: Journal of Cell BiologyPublisher: Rockefeller University PressVol: 223Issue #: 12Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-by, cc-byDOI - Digital Object Identifier: 10.1083/jcb.202311189Best OA location URL: https://doi.org/10.1083/jcb.202311189Citation Count: 4
- Impact of excessive daytime sleepiness on the progression of freezing of gait in de novo Parkinson’s disease: a cohort study2024OPENTitle: Impact of excessive daytime sleepiness on the progression of freezing of gait in de novo Parkinson’s disease: a cohort studyJournal Name: Neurological SciencesPublisher: Springer Science and Business Media LLCVol: 46Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s10072-024-07738-8Best OA location URL: https://doi.org/10.1007/s10072-024-07738-8Citation Count: 0
- Topography of Cholinergic Nerve Terminal Vulnerability and Balance Self-Efficacy in Parkinson's Disease2024OPENTitle: Topography of Cholinergic Nerve Terminal Vulnerability and Balance Self-Efficacy in Parkinson's DiseaseJournal Name: Journal of Integrative NeurosciencePublisher: IMR PressVol: 23Issue #: 9Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.31083/j.jin2309178Citation Count: 1
- Functional efficacy of the MAO-B inhibitor safinamide in murine substantia nigra pars compacta dopaminergic neurons in vitro: a comparative study with tranylcypromine2024OPENTitle: Functional efficacy of the MAO-B inhibitor safinamide in murine substantia nigra pars compacta dopaminergic neurons in vitro: a comparative study with tranylcypromineJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 128Issue #:Start Page: 107158End Page: 107158Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2024.107158Best OA location URL: https://doi.org/10.1016/j.parkreldis.2024.107158Citation Count: 1
- Advancing Parkinson’s Disease Research in Canada: The Canadian Open Parkinson Network (C-OPN) Cohort2024OPENTitle: Advancing Parkinson’s Disease Research in Canada: The Canadian Open Parkinson Network (C-OPN) CohortJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 14Issue #: 7Start Page: 1481End Page: 1494Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-240213Best OA location URL: https://doi.org/10.3233/jpd-240213Citation Count: 0
- Cross‐Sectional and Prospective Associations between Parkinsonism and Parkinson's Disease with Frailty in Latin America2024OPENTitle: Cross‐Sectional and Prospective Associations between Parkinsonism and Parkinson's Disease with Frailty in Latin AmericaJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 11Issue #: 12Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/mdc3.14214Citation Count: 0
-
OPENTitle: CYP1B1-RMDN2 Alzheimer’s disease endophenotype locus identified for cerebral tau PETJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41467-024-52298-2Citation Count: 2
- Evaluation of Cerebrospinal Fluid α‐Synuclein Seed Amplification Assay in Progressive Supranuclear Palsy and Corticobasal Syndrome2024OPENTitle: Evaluation of Cerebrospinal Fluid α‐Synuclein Seed Amplification Assay in Progressive Supranuclear Palsy and Corticobasal SyndromeJournal Name: Movement DisordersPublisher: WileyVol: 39Issue #: 12Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/mds.30019Citation Count: 2
-
OPENTitle: Activation of parkin by a molecular glueJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41467-024-51889-3Best OA location URL: https://doi.org/10.1038/s41467-024-51889-3Citation Count: 5
-
RESTRICTEDTitle: RAB32 Variants in a German Parkinson's Disease CohortJournal Name: Movement DisordersPublisher: WileyVol: 39Issue #: 11Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.30005Citation Count: 3
-
OPENTitle: An interpretable deep learning framework identifies proteomic drivers of Alzheimer’s diseaseJournal Name: Frontiers in Cell and Developmental BiologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fcell.2024.1379984Citation Count: 4
- Head-up Tilt Sleeping to Treat Orthostatic Intolerance in a Patient with Advanced Parkinson’s Disease: A Case Report2024OPENTitle: Head-up Tilt Sleeping to Treat Orthostatic Intolerance in a Patient with Advanced Parkinson’s Disease: A Case ReportJournal Name: Case Reports in NeurologyPublisher: S. Karger AGVol: 16Issue #: 1Start Page: 256End Page: 261Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1159/000541424Citation Count: 0
- How storage post sampling influences the stability of sebum when used for mass spectrometry metabolomics analysis?2024OPENTitle: How storage post sampling influences the stability of sebum when used for mass spectrometry metabolomics analysis?Journal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41598-024-71598-7Best OA location URL: https://doi.org/10.1038/s41598-024-71598-7Citation Count: 1
- NeuroBooster Array: A Genome‐Wide Genotyping Platform to Study Neurological Disorders Across Diverse Populations2024OPENTitle: NeuroBooster Array: A Genome‐Wide Genotyping Platform to Study Neurological Disorders Across Diverse PopulationsJournal Name: Movement DisordersPublisher: WileyVol: 39Issue #: 11Start Page: 2039End Page: 2048Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/mds.29902Citation Count: 11
- Viral overexpression of human alpha-synuclein in mouse substantia nigra dopamine neurons results in hyperdopaminergia but no neurodegeneration2024OPENTitle: Viral overexpression of human alpha-synuclein in mouse substantia nigra dopamine neurons results in hyperdopaminergia but no neurodegenerationJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 382Issue #:Start Page: 114959End Page: 114959Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.expneurol.2024.114959Best OA location URL: https://doi.org/10.1016/j.expneurol.2024.114959Citation Count: 1
- Cohort-specific Boolean models highlight different regulatory modules during Parkinson’s disease progression2024OPENTitle: Cohort-specific Boolean models highlight different regulatory modules during Parkinson’s disease progressionJournal Name: iSciencePublisher: Elsevier BVVol: 27Issue #: 10Start Page: 110956End Page: 110956Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.isci.2024.110956Citation Count: 1
-
OPENTitle: A Novel MAG Variant Causes Hereditary Spastic Paraplegia in a Consanguineous Pakistani FamilyJournal Name: GenesPublisher: MDPI AGVol: 15Issue #: 9Start Page: 1203End Page: 1203Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-by, cc-byDOI - Digital Object Identifier: 10.3390/genes15091203Best OA location URL: https://doi.org/10.3390/genes15091203Citation Count: 1
- Increasing hexokinase 1 expression improves mitochondrial and glycolytic functional deficits seen in sporadic Alzheimer’s disease astrocytes2024OPENTitle: Increasing hexokinase 1 expression improves mitochondrial and glycolytic functional deficits seen in sporadic Alzheimer’s disease astrocytesJournal Name: Molecular PsychiatryPublisher: Springer Science and Business Media LLCVol: 30Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41380-024-02746-8Best OA location URL: https://www.nature.com/articles/s41380-024-02746-8.pdfCitation Count: 1
- Structural and Functional Characterization of the Most Frequent Pathogenic PRKN Substitution p.R275W2024OPENTitle: Structural and Functional Characterization of the Most Frequent Pathogenic PRKN Substitution p.R275WJournal Name: CellsPublisher: MDPI AGVol: 13Issue #: 18Start Page: 1540End Page: 1540Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells13181540Citation Count: 1
- RTP801 interacts with the tRNA ligase complex and dysregulates its RNA ligase activity in Alzheimer’s disease2024OPENTitle: RTP801 interacts with the tRNA ligase complex and dysregulates its RNA ligase activity in Alzheimer’s diseaseJournal Name: Nucleic Acids ResearchPublisher: Oxford University Press (OUP)Vol: 52Issue #: 18Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/nar/gkae776Best OA location URL: https://doi.org/10.1093/nar/gkae776Citation Count: 0
-
OPENTitle: Understanding what aspects of Parkinson’s disease matter most to patients and familiesJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41598-024-71555-4Best OA location URL: https://doi.org/10.1038/s41598-024-71555-4Citation Count: 4
-
RESTRICTEDTitle: Validating New Symptom Emergence as a Patient-Centric Outcome Measure for PD Clinical TrialsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 128Issue #:Start Page: 107118End Page: 107118Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2024.107118Best OA location URL: https://doi.org/10.1016/j.parkreldis.2024.107118Citation Count: 0